Department of 5th Internal Medicine with Endocrinology, Rheumatology and Gerontology, Clinic Ottakring, 1160 Vienna, Austria.
Division of Endocrinology and Diabetology, Medical University of Graz, 8036 Graz, Austria.
Biosensors (Basel). 2024 Sep 21;14(9):451. doi: 10.3390/bios14090451.
Adolescence remains a crucial age associated with diabetes distress in individuals living with type 1 diabetes (T1D). The Austrian organization "Diabär" regularly hosts a one-week adventure camp for adolescents (12-18 years) living with T1D. The camp focuses on "fun activities" without a structured educational protocol in order to minimize diabetes distress and increase diabetes management skills. In contrast to educational camps, training is kept to a minimum. However, attendees analyze the glycemic data of the previous day with their medical supervisor once daily during the camp. All subjects used a standardized real-time continuous glucose monitoring (CGM) system (DexcomG7) throughout the whole study. Glycemic metrics were prospectively analyzed during three periods: week 1 = home phase, week 2 = adventure camp, and week 3 = after the camp. Safety (time below range 1 [TBR1], 69-54 mg/dL, and time below range 2 [TBR2], <54 mg/dL) and efficacy (time in range [TIR], 70-180 mg/dL) were assessed by comparing the CGM data during weeks 1-3. The CGM data of 14 participants were analyzed. The TIR was higher during the camp week versus week 1 (70.4 ± 11.1% vs. 53.1 ± 20.2%; = 0.001). The TBR1 significantly increased during camp compared to week 1 (2.5 ±1.7% vs. 1.3 ± 1.2%; = 0.009), whereas the TBR2 did not differ. No serious adverse events occurred. This adventure camp without a main focus on education showed feasibility and safety in adolescents with T1D.
青春期仍然是一个关键时期,与 1 型糖尿病(T1D)患者的糖尿病困扰有关。奥地利组织“Diabär”定期为患有 T1D 的青少年(12-18 岁)举办为期一周的冒险营。该营地侧重于“有趣的活动”,没有结构化的教育方案,以尽量减少糖尿病困扰并提高糖尿病管理技能。与教育营不同,培训保持在最低限度。然而,与会者每天在营地期间与他们的医疗主管一起分析前一天的血糖数据。所有受试者在整个研究中都使用了标准化的实时连续血糖监测(CGM)系统(DexcomG7)。血糖指标在三个时期进行前瞻性分析:第 1 周=家庭阶段,第 2 周=冒险营,第 3 周=营地之后。通过比较第 1-3 周的 CGM 数据来评估安全性(TBR1 以下时间,69-54mg/dL,和 TBR2 以下时间,<54mg/dL)和疗效(TIR,70-180mg/dL)。分析了 14 名参与者的 CGM 数据。与第 1 周相比,营地周的 TIR 更高(70.4±11.1% vs. 53.1±20.2%; = 0.001)。与第 1 周相比,营地期间 TBR1 显著增加(2.5±1.7% vs. 1.3±1.2%; = 0.009),而 TBR2 没有差异。没有发生严重不良事件。这个没有主要教育重点的冒险营在 T1D 青少年中显示出了可行性和安全性。